Switch to:
More From Other Websites
AstraZeneca wins FDA approval for expanded use of blood thinner Sep 04 2015
Pfizer Inc. -- Moody's assigns A1 to Pfizer's proposed exchange notes Sep 03 2015
Pfizer Inc. Commences Exchange Offers for Hospira Notes Sep 03 2015
Pfizer Inc. Commences Exchange Offers for Hospira Notes Sep 03 2015
Ex-Hospira CEO Trades Shares for $91 Million Cash in Pfizer Deal Sep 03 2015
PFIZER INC Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Regulation FD... Sep 03 2015
Pfizer (PFE) Stock Gains After Closing Hospira Acquisition Sep 03 2015
Pfizer Completes Acquisition of Hospira Sep 03 2015
9:06 am Pfizer completes its acquisition of Hospira (HSP) Sep 03 2015
Pfizer Completes Acquisition of Hospira Sep 03 2015
Pfizer Completes Acquisition of Hospira Sep 03 2015
Research and Markets: Linezolid: Developed by Pharmacia & Upjohn - Investigation Report on China's... Sep 03 2015
Finding Sustainable and Growing Dividends Among U.S. Equity Funds Sep 03 2015
UK Study Indicates That The Cardiovascular Risk Of Celebrex No Different From Other Pain Drugs Sep 02 2015
Pfizer's Effort to Toss Medicaid Lawsuit Seemingly Unsuccessful Sep 01 2015
Should You Sell GE, AT&T, Pfizer? Check Weekly Charts Aug 31 2015
The 4 Stocks That Hobbled the Dow on Monday Aug 31 2015
5 Dividend Stocks With Upside Potential: Apple Inc. (AAPL), Microsoft Corporation (MSFT) & More Aug 31 2015


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

User Comments

SEENSCO
ReplySEENSCO - 1 year ago
PFE is trading at the low end of our short-term valuation range ($29-$36) and significantly below our Fair Value estimate of $42.41.


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK